Smith GI, Villareal DT, Lambert CP, Reeds DN, Mohammed BS, Mittendorfer B. Timing of the initial muscle biopsy does not affect the measured muscle protein fractional synthesis rate during basal, postabsorptive conditions. J Appl Physiol 108: 363-368, 2010. First published November 25, 2009 doi:10.1152/japplphysiol.00957.2009.-The muscle protein fractional synthesis rate (FSR) is determined by monitoring the incorporation of an amino acid tracer into muscle protein during a constant-rate intravenous tracer infusion. Commonly two sequential muscle biopsies are obtained some time after starting the tracer infusion. However, other protocols, including those with an initial biopsy before starting the tracer infusion to measure the background enrichment and those with only a single biopsy after several hours of tracer infusion have been used. To assess the validity of these approaches, we compared the muscle protein FSR obtained by calculating the difference in [ring-2 H5]phenylalanine and [5,5, H3]leucine incorporation into muscle protein at ϳ3.5 h after starting the tracer infusion and 1) at 60 min; 2) before starting the tracer infusion (background enrichment); 3) a population average muscle protein background enrichment; and 4) by measuring the tracer incorporation into muscle protein at ϳ3.5 h assuming essentially no background enrichment. Irrespective of the tracer used, the muscle protein FSR calculated from the difference in the muscle protein labeling several hours after starting the tracer infusion and either the labeling at 60 min or the background enrichment were not different (e.g., 0.049 Ϯ 0.007%/h vs. 0.049 Ϯ 0.007%/h, respectively, with [ ]leucine, respectively. We conclude that during basal, postabsorptive conditions, valid muscle protein FSR values can be obtained irrespective of the timing of the initial biopsy so long as the protein labeling in two sequential biopsies is measured whereas the single biopsy approach should be avoided. amino acid; muscle protein turnover PROTEIN SYNTHESIS RATES in human muscles are commonly determined by measuring the difference in incorporation of a stable isotope-labeled amino acid tracer (usually phenylalanine or leucine) into muscle protein between two sequential biopsies during a primed, continuous intravenous infusion of the tracer (2,13,15,25,27,35,37,44,45,48). The muscle protein fractional synthesis rate (FSR) is then calculated by dividing the increment in label incorporation over time by the labeling of the precursor for protein synthesis [ideally the labeling of the aminoacyl-tRNA specific for the tracer amino acid infused, but a number of surrogates have been proposed and used (23,46,47)]. For this approach to be valid, it is necessary that label incorporation into proteins proceeds in a linear manner, which is the case if the precursor pool is steady during that time. Thus it has been recommended to administer the primed constant tracer infusion for at least 1 h before the first biopsy (47). Indeed many protocols have been designed with an initial muscl...